Flagship Pioneering

Flagship Pioneering

Signal active

Investment Firm

Overview

Flagship Pioneering conceives, creates, resources, and grows first-in-category ventures to transform human health and sustainability. The company accelerates Flagship Pioneering’s advances in biology, engineering, medicine, energy, and beyond. The firm harnesses science and entrepreneurialism to envision alternative futures, beginning with seemingly unreasonable propositions and navigating to transformational outcomes through an evolutionary methodology.

Flagship Pioneering combines innovative capacity, entrepreneurial leadership, and professional capital management in a single enterprise that systematically produces first-in-category companies.

Highlights

Founded

2000

Industry

Venture Capital

Employees

5001-10000

Investment

274

Lead Investment

96

Exits

66

Stages

Early Stage Venture, Late Stage Venture, Seed, Private Equity

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

Flagship Pioneering, established in 2000 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Seed, Private Equity investments across Information Services, Marketing, Analytics, Lead Generation, Financial Services, Venture Capital, Finance, Security, Software, Cyber Security. The organization boasts a portfolio of 274 investments, with an average round size of $61.2M and 66 successful exits. Their recent investments include ZoomInfo, Commonwealth Capital Ventures, Venrock, Vulcan Capital, Ascent Venture Partners. The highest investment round they participated in was $853.0B. Among their most notable exits are ZoomInfo and Commonwealth Capital Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Noubar Afeyan

Noubar Afeyan

Founder & CEO

imagePlace Harry Wilcox

Harry Wilcox

General Partner

imagePlace Douglas Cole

Douglas Cole

Managing Partner

imagePlace Bill Johnson

Bill Johnson

Vice President of Finance

imagePlace Avak Kahvejian

Avak Kahvejian

General Partner

imagePlace Geoffrey von Maltzahn

Geoffrey von Maltzahn

General Partner

Investment portfolio

Flagship Pioneering has made 274 investments. Their most recent investment was on May 07, 2024, when Prologue Medicines raised $50.0M.

Flagship Pioneering has made 45 diversity investments. Their most recent diversity investment was on Dec 19, 2023, when Syros Pharmaceuticals raised $45.0M.

investments

274

Diversity investments

45

Lead investments

96

Number of exits

66

Investments

274

Annouced DateOrganization NameIndustryMoney Raised
Nov 21, 2023
Quotient Therapeutics Quotient Therapeutics
Biotechnology50.0M
Dec 19, 2023
Syros Pharmaceuticals Syros Pharmaceuticals
Biotechnology45.0M
Jan 30, 2024--103.0M
May 07, 2024
Prologue Medicines Prologue Medicines
Health Care50.0M

Exits

66

Funding Timeline

Funding rounds

274

Investors

0

Funds

9

Funding Rounds

274

Flagship Pioneering has raised 274 rounds. Their latest funding was raised on May 07, 2024 from a Series A - Prologue Medicines round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Nov 21, 2023
Seed Round - Quotient Therapeutics Seed Round - Quotient Therapeutics
-50.0M-
Dec 19, 2023
Post-IPO Equity - Syros Pharmaceuticals Post-IPO Equity - Syros Pharmaceuticals
-45.0M-
Jan 30, 2024
Series F - Inari Series F - Inari
-103.0M-
May 07, 2024
Series A - Prologue Medicines Series A - Prologue Medicines
-50.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.